-
Canine splenic hemangiosarcoma remains a major therapeutic challenge. This presentation reviews conventional and emerging integrative evidence, then traces the development of a standardised, multi-target nutraceutical, from clinical observations and biological rationale through a clinical experience program toward prospective investigation
Get Tickets
Free - $50.00